Relationship between transforming growth factor &beta;1 and anti-fibrotic effect of interleukin-10

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

361

HTML

2004

Figures (1-5)

121

Tables (1-4)

125

Sum=2611

Apr 21, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 21, 2006; 12(15): 2357-2362
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2357

Table 3 Expression of TGF-β1 mRNA in HSCs (mean ± SE)

^b P < 0.01 vs group N;

^d P < 0.01 vs group C ;

^a P < 0.05 vs wk 7.

Citation: Shi MN, Huang YH, Zheng WD, Zhang LJ, Chen ZX, Wang XZ. Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10. World J Gastroenterol 2006; 12(15): 2357-2362
URL: https://www.wjgnet.com/1007-9327/full/v12/i15/2357.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i15.2357